1. Home
  2. VIR vs BITF Comparison

VIR vs BITF Comparison

Compare VIR & BITF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • BITF
  • Stock Information
  • Founded
  • VIR 2016
  • BITF 2017
  • Country
  • VIR United States
  • BITF Canada
  • Employees
  • VIR N/A
  • BITF N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • BITF Finance: Consumer Services
  • Sector
  • VIR Health Care
  • BITF Finance
  • Exchange
  • VIR Nasdaq
  • BITF Nasdaq
  • Market Cap
  • VIR 706.4M
  • BITF 564.7M
  • IPO Year
  • VIR 2019
  • BITF N/A
  • Fundamental
  • Price
  • VIR $5.65
  • BITF $1.07
  • Analyst Decision
  • VIR Strong Buy
  • BITF Strong Buy
  • Analyst Count
  • VIR 8
  • BITF 3
  • Target Price
  • VIR $30.25
  • BITF $4.83
  • AVG Volume (30 Days)
  • VIR 1.2M
  • BITF 16.8M
  • Earning Date
  • VIR 07-31-2025
  • BITF 08-07-2025
  • Dividend Yield
  • VIR N/A
  • BITF N/A
  • EPS Growth
  • VIR N/A
  • BITF N/A
  • EPS
  • VIR N/A
  • BITF N/A
  • Revenue
  • VIR $20,861,000.00
  • BITF $209,412,000.00
  • Revenue This Year
  • VIR N/A
  • BITF $88.01
  • Revenue Next Year
  • VIR $0.62
  • BITF $84.80
  • P/E Ratio
  • VIR N/A
  • BITF N/A
  • Revenue Growth
  • VIR N/A
  • BITF 25.67
  • 52 Week Low
  • VIR $4.32
  • BITF $0.67
  • 52 Week High
  • VIR $14.45
  • BITF $3.15
  • Technical
  • Relative Strength Index (RSI)
  • VIR 57.21
  • BITF 66.37
  • Support Level
  • VIR $5.20
  • BITF $0.98
  • Resistance Level
  • VIR $6.23
  • BITF $1.09
  • Average True Range (ATR)
  • VIR 0.30
  • BITF 0.08
  • MACD
  • VIR 0.07
  • BITF 0.03
  • Stochastic Oscillator
  • VIR 56.06
  • BITF 82.22

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About BITF Bitfarms Ltd.

Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.

Share on Social Networks: